The results shown in Figures S1C and S1D further support the activation of a GCN2/ATF4-dependent, but CHOP-independent, signaling pathway that drives IL-8 upregulation in glutamine-deprived HCT116 tumor cells. Here, CXCL8 is linked to neoplasm.